PF-514273 is a drug developed by Pfizer which acts as an extremely selective antagonist for the CB1 receptor with approximately 10000x selectivity over the closely related CB2 receptor. This very high selectivity makes it useful for scientific research into these receptors as many commonly used cannabinoid receptor antagonists also block the CB2 receptor to some extent.
This page contains content from the copyrighted Wikipedia article "PF-514273"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
